Marianna Fontana
Overview
Explore the profile of Marianna Fontana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
300
Citations
10149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Judge D, Alexander K, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, et al.
J Am Coll Cardiol
. 2025 Mar;
85(10):1003-1014.
PMID: 40074465
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed chronic disease associated with progressive heart failure that results in impaired quality of life, repeated hospitalizations, and premature death. Acoramidis is a...
2.
Fontana M, Fumagalli C, Cappelli F
Eur Heart J
. 2025 Mar;
46(11):1071-1073.
PMID: 40036253
No abstract available.
3.
Khwaja J, Ravichandran S, Cohen O, Foard D, Low M, Martinez-Naharro A, et al.
Br J Haematol
. 2025 Feb;
PMID: 39980430
Systemic light chain (AL) amyloidosis is an incurable disorder caused by extra-cellular deposition of light-chain aggregates in critical organs. An immunomodulatory agent-based quadruplet including anti-CD38 therapy has not been investigated...
4.
Porcari A, Fontana M, Riefolo M
Circ Heart Fail
. 2025 Jan;
18(2):e012652.
PMID: 39866120
No abstract available.
5.
Fontana M, Maurer M, Gillmore J, Bender S, Jay P, Solomon S
J Am Coll Cardiol
. 2025 Jan;
85(7):744-752.
PMID: 39846936
Background: Outpatient worsening heart failure (HF), defined by initiation or intensification of diuretics, is adversely prognostic for patients with either reduced or preserved ejection fraction. Objectives: This study sought to...
6.
Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al.
JAMA Cardiol
. 2025 Jan;
PMID: 39841451
Importance: Patients with transthyretin (ATTR) cardiac amyloid infiltration are increasingly diagnosed at earlier disease stages with no heart failure (HF) symptoms and a wide range of cardiac amyloid infiltration. Objective:...
7.
Khwaja J, Ravichandran S, Cohen O, Foard D, Martinez-Naharro A, Venneri L, et al.
Haematologica
. 2025 Jan;
PMID: 39815808
Not available.
8.
Sade L, Faletra F, Pontone G, Gerber B, Muraru D, Edvardsen T, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Jan;
26(3):385-413.
PMID: 39812172
Structural, architectural, contractile, or electrophysiological alterations may occur in the left atrium (LA). The concept of LA cardiopathy is supported by accumulating scientific evidence demonstrating that LA remodelling has become...
9.
Fontana M, Ioannou A, Cuddy S, Dorbala S, Masri A, Moon J, et al.
JACC Cardiovasc Imaging
. 2025 Jan;
PMID: 39797879
Cardiac amyloidosis represents a unique disease process characterized by amyloid fibril deposition within the myocardial extracellular space. Advances in multimodality cardiac imaging enable accurate diagnosis and facilitate prompt initiation of...
10.
Arnold J, Yeo J, Budgeon C, Shergill S, England R, Shiwani H, et al.
Int J Cardiovasc Imaging
. 2024 Dec;
41(2):247-256.
PMID: 39738791
The pathophysiology of myocardial injury following COVID-19 remains uncertain. COVID-HEART was a prospective, multicentre study utilising cardiovascular magnetic resonance (CMR) to characterise COVID-related myocardial injury. In this pre-specified analysis, the...